Piroxicam, mitoxantrone, and coarse fraction radiotherapy for the treatment of transitional cell carcinoma of the bladder in 10 dogs: A pilot study

Journal of the American Animal Hospital Association

Volumn 40, Issue 2, 2004, Pages 131-136

  Poirier, Valerie J ^a   Forrest, Lisa J ^a   Adams, William M ^a   Vail, David M ^a  

^a UNIVERSITY OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOXANTRONE; PIROXICAM;

ARTICLE; BLADDER CARCINOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL FEATURE; CLINICAL PROTOCOL; COBALT THERAPY; CONTROLLED STUDY; DERMATITIS; DESQUAMATION; DRUG TOLERABILITY; ERYTHEMA; GASTROINTESTINAL TOXICITY; LETHARGY; NEUTROPENIA; NONHUMAN; SURVIVAL TIME; TRANSITIONAL CELL CARCINOMA; VOMITING;

CANIS FAMILIARIS;

EID: 24644485977     PISSN: 15473317     EISSN: 15473317     Source Type: Journal    
DOI: 10.5326/0400131     Document Type: Article

References (23)

1. Osborne CA, Low DG, Perman V, et al. Neoplasms of the canine and feline urinary bladder: incidence, etiologic factors, occurrence and pathologic features. Am J Vet Res 1968;29:2041-2055.
2. Norris AM, Laing EJ, Valli VE, et al. Canine bladder and urethral tumors: a retrospective study of 115 cases (1980-1985). J Vet Intern Med 1992;6:145-153.
3. Knapp DW, Glickman NW, DeNicola DB, et al. Naturally-occurring canine transitional cell carcinoma of the urinary bladder: a relevant model of human invasive bladder cancer. Urol Oncol 2000;5:47-59.
4. Valli VE, Norris A, Jacobs RM, et al. Pathology of canine bladder and urethral cancer and correlation with tumour progression and survival. J Comp Path 1995;113:113-130.
5. Stone EA, Withrow SJ, Page RL, et al. Ureterocolonic anastomosis in ten dogs with transitional cell carcinoma. Vet Surg 1988;17:147-153.
6. Helfand SC, Hamilton TA, Hungerford LL, et al. Comparison of three treatments for transitional cell carcinoma of the bladder in dogs. J Am Anim Hosp Assoc 1994;30:270-275.
7. Stone EA, George TF, Gilson SD, et al. Partial cystectomy for bladder neoplasia: surgical technique and outcome of 11 dogs. J Small Anim Pract 1996;37:480-485.
8. Chun R, Knapp DW, Widmer WR, et al. Cisplatin treatment of transitional cell carcinoma of the urinary bladder in dogs: 18 cases (1983-1993). J Am Vet Med Assoc 1996;9:1588-1592.
9. Moore AS, Cardona A, Shapiro W, et al. Cisplatin (cisdiamminedichloroplatinum) for treatment of transitional cell carcinoma of the urinary bladder or urethra: a retrospective study of 15 dogs. J Vet Intern Med 1990;4:148-152.
10. Shapiro W, Kitchell BE, Fossum TW, et al. Cisplatin for treatment of transitional cell and squamous cell carcinomas in dogs. J Am Vet Med Assoc 1988;193:1530-1533.
11. Ogilvie GK, Obradovich JE, Emslie RE, et al. Efficacy of mitoxantrone against various neoplasms in dogs. J Am Vet Med Assoc 1991;198:1618-1621.
12. Walker M, Breider M. Intraoperative radiotherapy of canine bladder cancer. Vet Radiol 1987;28:200-204.
13. Withrow SJ, Gillette EL, Hoopes PJ, et al. Intraoperative irradiation of 16 spontaneously occurring canine neoplasms. Vet Surg 1989;18:7-11.
14. Knapp DW, Richardson RC, Chan TCK, et al. Piroxicam therapy in 34 dogs with transitional cell carcinoma of the urinary bladder. J Vet Intern Med 1994;8:273-278.
15. Mohammed SI, Bennett PF, Craig BA, et al. Effects of the cyclooxygenase inhibitor, piroxicam, on tumor response, apoptosis, and angiogenesis in canine model of human invasive urinary bladder cancer. Canc Res 2002;62:356-358.
16. Henry CJ, McCaw DL,Turnquist SE, et al. Clinical evaluation of mitoxantrone and piroxicam in a canine model of human invasive urinary bladder carcinoma. Clin Canc Res 2003;9(2):906-911.
17. Herr HW, Shipley WU, Bajorin DF. Cancer of the bladder. In: DeVita VT, Hellman S, Rosenberg SA, eds. Cancer: Principles & Practice of Oncology. 6th ed. Philadelphia: Lippincott Williams & Wilkins, 2001:1396-1415.
18. Rostom AY, Tahir S, Gershuny AR, et al. Once weekly irradiation for carcinoma of the bladder. Int J Rad Oncol Biol Phys 1996;35:289-292.
19. Ladue T, Klein MK. Toxicity criteria of the veterinary radiation therapy oncology group. Vet Radiol Ultrasound 2001;42(5):475-476.
20. Owen LN. TNM classification of tumors in domestic animals. Geneva: World Health Organization, 1980:34.
21. Anderson CR, McNiel EA, Gillette EL, et al. Late complication of pelvic irradiation in 16 dogs. Vet Radiol Ultrasound 2002;43(2):187-192.
22. Ogilvie GK. Moore AS, Chen C, et al. Toxicoses associated with the administration of mitoxantrone to dogs with malignant tumors: a dose escalation study. J Am Vet Med Assoc 1994;205:570-573.
23. Ogilvie GK, Obradovich JE, Emslie RE, et al. Toxicoses associated with administration of mitoxantrone to dogs with malignant tumors. J Am Vet Med Assoc 1991;198:1613-1617.